A pioneer in the diagnostic uses of radiation and the development and testing of
radiotracers in the early days of nuclear medicine, Robert N. Beck, professor emeritus in the Department of Radiology at the University of Chicago, died at the University of Chicago Medical Center on August 6, 2008, from myelodysplasia, a form of leukemia.
The researchers have obtained FDA approval to begin testing
the radiotracer in humans and scanned about a dozen volunteers thus far.
Not exact matches
Richard Hargreaves, executive director of imaging at Merck Research Laboratories, says, «Nuclear imaging using
radiotracers gives the opportunity to put your arms around proof - of - concept very early
in a drug discovery and development program by focusing the selection of doses to study on those proven to deliver enough drug to the target therapeutic sites.»
Our current multi-centre pivotal study has shown that
in many patients, by using a
radiotracer with a novel receptor - based mechanism, the SN can be reliably identified and removed for biopsy without having to undertake more extensive surgery.
«New
radiotracer helps avoid neck dissection
in patients with early head and neck cancer.»
For this research, a total of 28 subjects were imaged with a variety of imaging modalities, including standard imaging with computed tomography, magnetic resonance imaging and molecular bone scan (SI); PET with a common
radiotracer called fluorodeoxyglucose (FDG - PET); and PET with computed tomography and the agent Zr - 89 IAB2M (IAB2M PET / CT) assessed
in escalated doses.
The researchers now plan to start a study
in the EU
in which patients will undergo SN mapping (lymphoscintigraphy) after injection of both types of
radiotracers.
The scientists used Brookhaven's Cyclotron — a small accelerator dedicated to isotope production — to produce the nitrogen
radiotracer, which was then introduced to the soil
in a stream of air.
«Novel
radiotracer measures olfactory neurons
in animal models: Tracking deterioration
in sense of smell could provide early diagnosis of neurodegenerative disease.»
For the JCI study, the team applied the
radiotracer to monitor olfactory sensory neuron population dynamics
in a rodent model, using PET to measure its uptake across the animals» lifespan, including during age - related neurodegeneration.
Dr James Rudd, a cardiologist and researcher from the Department of Cardiovascular Medicine at the University of Cambridge adds: «Sodium fluoride is a simple and inexpensive
radiotracer that should revolutionise our ability to detect dangerous calcium
in the arteries of the heart and brain.
This confirmed that the
radiotracer accumulates
in areas of active, unstable calcification whilst avoiding surrounding tissue.
For this study, 10 subjects with Alzheimer's underwent PET following the injection of three
radiotracers: fluorine - 18 fluorodeoxyglucose (F - 18 FDG), which images regional metabolic activity; carbon - 11 Pittsburgh compound B (C - 11 PiB), which has an affinity for amyloid plaques; and F - 18 AV - 1451, an emerging imaging agent that binds to tau
in the brain.
The development of
radiotracers like this could radically change drug development, especially for neurological disorders, which are notoriously difficult to study
in animal models.
Their discovery could aid
in the synthesis of new «
radiotracers» — chemical compounds that contain a radioactive form, or isotope, of an element — for use with a noninvasive, high - resolution 3 - D medical imaging technology known as PET (positron emission tomography) scanning.
Because the study used cognitive stress as a challenge, it was not confounded by potential group differences
in stimulant - induced changes
in cerebellar
radiotracer delivery.
The mechanism underlying the lack of an effect of MP
in cerebellar DV
in abusers is unclear but could reflect the effects of chronic marijuana on cerebrovascular reactivity (increased cerebral vascular resistance)(23 ⇓ — 25), which might have prevented MP - induced vasoconstriction and associated reductions
in radiotracer delivery to the brain.
Interestingly, an imaging study comparing DA increases using BPND and 4 - propyl -9-hydroxynaphthoxazine -LRB-[11C] PHNO)(
radiotracer with > 20-fold higher affinity for D3 over D2 receptors, and presumably more sensitive to competition with endogenous DA)(63, 64)
in response to a stressor
in individuals at high risk for schizophrenia showed that those who abused marijuana had a blunted response, consistent with decreased DA signaling (22).
Brookhaven scientist Joanna Fowler describes Positron Emission Technology (PET) research at BNL which for the past 30 years has focused
in the integration of basic research
in radiotracer chemistry with the tools of neuroscience to develop new scientific tools for applications
in human health.
On Friday, October 19, 2012, the New York Section of the American Chemical Society (ACS) named Brookhaven Lab's Chemistry Building an Historic Chemical Landmark,
in recognition of the synthesis of 18FDG, the first successful
radiotracer for positron emission tomography (PET) imaging.
Measuring tau deposits using the novel
radiotracer 18F - AV - 1451 (18F - T807),
in conjunction with 11C - PiB to measure amyloid plaques and 18F - FDG to measure regional neurodegeneration, offers new insight into the neurodegenerative characteristics of Alzheimer's disease and shows that tau pathology may be an instrumental target for disease - modifying strategies.
San Diego, Calif. (Embargoed until 1:15 PM on Wednesday, June 15)-- Positron emission tomography (PET) with three different
radiotracers can now measure amyloid plaques, tau tangles and metabolic activity
in the brains of living Alzheimer's patients.